Saving eyesight, one gene at a time

Area of Science:

• Genetics
• Ophthalmology
• Molecular Biology

Background:

• Genetic mutations in the Pde6b gene are a common cause of inherited blindness in mice.
• Current gene editing technologies face limitations, including protospacer adjacent motif (PAM) sequence requirements.

Purpose of the Study:

• To investigate the efficacy of prime editing in correcting a specific mutation responsible for blindness in the mouse retina.
• To overcome PAM sequence limitations in gene editing for potential therapeutic applications.

Main Methods:

• Utilized prime editing technology to target and repair the Pde6b gene mutation in mouse retinal cells.
• Employed a Cas9 nickase variant that does not require a PAM sequence for its activity.

Main Results:

• Successfully repaired the blindness-causing Pde6b gene mutation in the mouse retina.
• Demonstrated the effectiveness of PAM-less Cas9 nickase in conjunction with prime editing.

Conclusions:

• Prime editing can be effectively used to correct disease-causing mutations in the retina.
• The development of PAM-independent Cas9 nickases significantly advances prime editing capabilities for gene therapy.